Published in Medicine (Baltimore) on November 01, 2016
Identification Of Blood Markers For Asymptomatic Ventricular Dysfunction (IBLOMAVED) | NCT01024049
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32
The failing heart--an engine out of fuel. N Engl J Med (2007) 12.06
Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet (2002) 4.86
Estimation of human body surface area from height and weight. Cancer Chemother Rep (1970) 4.17
Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med (2002) 3.91
Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation (2000) 3.68
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr (2016) 2.47
The progression of hypertensive heart disease. Circulation (2011) 2.42
Prognostic implications of left ventricular hypertrophy. Am Heart J (2001) 2.42
Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation (2006) 2.40
Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med (1988) 2.30
CaMK4 Gene Deletion Induces Hypertension. J Am Heart Assoc (2012) 2.14
G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. High Blood Press Cardiovasc Prev (2013) 2.13
Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med (1998) 2.12
Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation (2001) 2.10
Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol (2008) 1.92
Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation (2000) 1.82
Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin Chim Acta (1998) 1.81
Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension (2000) 1.81
Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. Hypertension (2010) 1.47
Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol (1994) 1.41
Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease. Hypertension (2003) 1.39
Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure. Circ Heart Fail (2010) 1.35
The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. J Hypertens (2007) 1.35
Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease. Nat Clin Pract Cardiovasc Med (2005) 1.34
Glucose metabolism and cardiac hypertrophy. Cardiovasc Res (2011) 1.28
Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J Biol Chem (2001) 1.26
The Strain of Detecting Early Target Organ Damage in Hypertension. J Am Coll Cardiol (2015) 1.24
Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens (2011) 1.23
Metabolic remodelling of the failing heart: beneficial or detrimental? Cardiovasc Res (2008) 1.22
Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis. Cardiology (2015) 1.19
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. BMC Cardiovasc Disord (2010) 1.12
A translational approach to hypertensive heart disease. Hypertension (2009) 1.07
Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens (2011) 1.07
Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol (1997) 1.05
Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts. Clin Sci (Lond) (2002) 1.02
Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease. Hypertension (2014) 1.02
The role of non-haemodynamic factors of the genesis of LVH. Nephrol Dial Transplant (2005) 1.00
Echocardiographic Evaluation of Left Atrial Mechanics: Function, History, Novel Techniques, Advantages, and Pitfalls. Biomed Res Int (2015) 0.99
Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart (2005) 0.96
Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. Clin Transl Sci (2008) 0.96
Increased left ventricular mass as a predictor of sudden cardiac death: is it time to put it to the test? Circ Arrhythm Electrophysiol (2013) 0.94
MicroRNAs and Endothelial (Dys) Function. J Cell Physiol (2015) 0.93
Speckle-tracking and tissue-Doppler stress echocardiography in arterial hypertension: a sensitive tool for detection of subclinical LV impairment. Biomed Res Int (2014) 0.92
Quantitative analysis of plasma acylcarnitines using gas chromatography chemical ionization mass fragmentography. J Lipid Res (1997) 0.92
Is plasma cardiotrophin-1 a marker of hypertensive heart disease? J Hypertens (2005) 0.91
Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass. Hypertension (1999) 0.91
Diagnostic Accuracy of Tissue Doppler Index E/e' for Evaluating Left Ventricular Filling Pressure and Diastolic Dysfunction/Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. J Am Heart Assoc (2016) 0.90
Masked hypertension is "unmasked" by low-intensity exercise blood pressure. Blood Press (2011) 0.89
Exercise-induced arterial hypertension - an independent factor for hypertrophy and a ticking clock for cardiac fatigue or atrial fibrillation in athletes? F1000Res (2014) 0.88
High-density lipoprotein cholesterol and insulin resistance are independent and additive markers of left ventricular hypertrophy in essential hypertension. Hypertens Res (2007) 0.87
Expression and localization of the annexins II, V, and VI in myocardium from patients with end-stage heart failure. Lab Invest (2000) 0.85
Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease. Cardiovasc Res (2005) 0.85
Left ventricular diastolic function in hypertension: methodological considerations and clinical implications. J Clin Med Res (2014) 0.83
Integrating GRK2 and NFkappaB in the Pathophysiology of Cardiac Hypertrophy. J Cardiovasc Transl Res (2015) 0.82
Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy. Mol Ther (2012) 0.80
Metabonomics analysis of plasma reveals the lactate to cholesterol ratio as an independent prognostic factor of short-term mortality in acute heart failure. PLoS One (2013) 0.78
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol (2005) 3.20
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol (2007) 3.09
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest (2009) 2.80
Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr (2008) 2.77
Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol (2013) 2.28
Adrenomedullin inhibits adipogenesis under transcriptional control of insulin. Diabetes (2007) 2.03
Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease. Ann Emerg Med (2007) 1.61
B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode. Eur Heart J (2009) 1.56
Engraftment of human T, B and NK cells in CB.17 SCID/beige mice by transfer of human spleen cells. Transpl Immunol (2005) 1.51
Poor blood pressure control in general practice: in search of explanations. Arch Cardiovasc Dis (2009) 1.50
Relationship between C reactive protein and pulse pressure is not mediated by atherosclerosis or aortic stiffness. J Hypertens (2004) 1.46
Risk of neurological decompression sickness in the diver with a right-to-left shunt: literature review and meta-analysis. Clin J Sport Med (2009) 1.46
A polymorphism in the endothelin-A receptor gene is linked to baroreflex sensitivity. J Hypertens (2005) 1.42
Retroperitoneoscopic adrenalectomy: comparison of retrograde and antegrade approach among a series of 279 cases. Urology (2013) 1.40
Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. Eur Heart J (2010) 1.23
Incremental value of global longitudinal strain for predicting early outcome after cardiac surgery. Eur Heart J Cardiovasc Imaging (2012) 1.19
Interleukin 6 is associated with subclinical atherosclerosis: a link with soluble intercellular adhesion molecule 1. J Hypertens (2006) 1.14
Why is hypertension so frequently uncontrolled in secondary prevention? J Hypertens (2003) 1.14
Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme. Eur J Heart Fail (2009) 1.11
Metabolic syndrome, insulin resistance, and periodontitis: a cross-sectional study in a middle-aged French population. J Clin Periodontol (2010) 1.11
Nonischemic heart failure in diabetes mellitus. Curr Opin Cardiol (2008) 1.09
Reversal of dilated cardiomyopathy by the elimination of frequent left or right premature ventricular contractions. J Interv Card Electrophysiol (2007) 1.06
Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study. Eur J Heart Fail (2012) 1.04
ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart. J Biol Chem (2006) 1.04
Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. J Hypertens (2012) 1.00
Mediastinal lymphadenopathy in congestive heart failure: a sequential CT evaluation with clinical and echocardiographic correlations. Eur Radiol (2003) 0.99
Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa). PLoS One (2009) 0.99
Real-time 3D transoesophageal echocardiography for guiding Amplatzer septal occluder device deployment in an adult patient with atrial septal defect. Eur J Echocardiogr (2008) 0.99
Relationship between time of day, day of the week and in-hospital mortality in patients undergoing emergency percutaneous coronary intervention. Arch Cardiovasc Dis (2009) 0.98
Insulin resistance protects the heart from fuel overload in dysregulated metabolic states. Am J Physiol Heart Circ Physiol (2013) 0.97
Patterns of hypertension management in France (ENNS 2006-2007). Eur J Prev Cardiol (2011) 0.96
Adiponectin and long-term mortality in coronary artery disease participants and controls. Arterioscler Thromb Vasc Biol (2012) 0.95
Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload. J Mol Cell Cardiol (2009) 0.94
Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis. Psychopharmacology (Berl) (2007) 0.94
Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK study). J Hypertens (2002) 0.93
Learning from recent trials and shaping the future of acute heart failure trials. Am Heart J (2013) 0.92
Anxiodepressive disorders and chronic psychological stress are associated with Tako-Tsubo cardiomyopathy- New Physiopathological Hypothesis. Circ J (2012) 0.92
Soluble CD14 and aortic stiffness in a population-based study. J Hypertens (2003) 0.92
Dopamine beta-hydroxylase deficiency. Orphanet J Rare Dis (2006) 0.92
Cardiac transcriptome analysis in obesity-related hypertension. Hypertension (2003) 0.91
Transcriptional regulation of adipocyte hormone-sensitive lipase by glucose. Diabetes (2002) 0.91
Left ventricular embolization of an aortic balloon-expandable bioprosthesis: balloon capture and reimpaction as an alternative to emergent conversion to open-heart surgery. JACC Cardiovasc Interv (2013) 0.91
Bortezomib and heart failure: case-report and review of the French Pharmacovigilance database. Fundam Clin Pharmacol (2013) 0.90
Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats. Peptides (2002) 0.90
A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam. Psychopharmacology (Berl) (2009) 0.90
The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro. Transpl Int (2005) 0.89
Thrombolysis by recombinant tissue plasminogen activator during pregnancy: a case of massive pulmonary embolism. Am J Emerg Med (2010) 0.89
Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart. J Clin Invest (2014) 0.89
Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats. Brain Res (2002) 0.89
Obesogenic high fat western diet induces oxidative stress and apoptosis in rat heart. Mol Cell Biochem (2010) 0.89
Blood signature of pre-heart failure: a microarrays study. PLoS One (2011) 0.88
Fluorine-19 or phosphorus-31 NMR spectroscopy: a suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs. J Pharm Biomed Anal (2005) 0.88
The role of stent-grafts in the management of aortic trauma. Cardiovasc Intervent Radiol (2011) 0.87
CD14 C(-260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis. J Hypertens (2004) 0.87
Relationship between left ventricular sphericity and trabeculation indexes in patients with dilated cardiomyopathy: a cardiac magnetic resonance study. Eur Heart J Cardiovasc Imaging (2013) 0.86
Is exercise testing useful to improve the prediction of coronary events in asymptomatic subjects? Eur J Cardiovasc Prev Rehabil (2006) 0.86
[Sleep apnea syndromes and cardiovascular disease]. Bull Acad Natl Med (2005) 0.86
Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation. J Hypertens (2009) 0.85
Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure. Clin Res Cardiol (2012) 0.85
Transfemoral aortic valve implantation with pre-existent mechanical mitral prosthesis: evidence of feasibility. JACC Cardiovasc Interv (2009) 0.85
High-intensity interval exercise improves vagal tone and decreases arrhythmias in chronic heart failure. Med Sci Sports Exerc (2013) 0.85
High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients. Am J Cardiovasc Drugs (2010) 0.85
Unusual presentation of primary toxoplasmosis infection in a kidney-transplant patient complicated by an acute left-ventricular failure. NDT Plus (2008) 0.85
New concept of myocardial longitudinal strain reserve assessed by a dipyridamole infusion using 2D-strain echocardiography: the impact of diabetes and age, and the prognostic value. Cardiovasc Diabetol (2013) 0.85
Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin-independent inhibitor of NFAT. Transpl Int (2004) 0.85
"CADASIL coma" in an Italian homozygous CADASIL patient: comparison with clinical and MRI findings in age-matched heterozygous patients with the same G528C NOTCH3 mutation. Neurol Sci (2013) 0.85
Plateins: a novel family of signal peptide-containing articulins in euplotid ciliates. J Eukaryot Microbiol (2003) 0.85
QT dynamicity: a prognostic factor for sudden cardiac death in chronic heart failure. Eur J Heart Fail (2005) 0.84